← FDA DRUG APPROVALS

FDA NDA · NDA212304

ADLARITY

Sponsor: CORIUM

APPLICATION
NDA212304
TYPE
NDA
ORIGINAL APPROVAL
2022-03-11
LATEST ACTION
2022-03-11
ROUTE
TRANSDERMAL
DOSAGE FORM
SYSTEM
MARKETING STATUS
Discontinued

Products

ADLARITY · ReferenceDiscontinued
DONEPEZIL HYDROCHLORIDE 10MG/DAY · SYSTEM · TRANSDERMAL
ADLARITY · ReferenceDiscontinued
DONEPEZIL HYDROCHLORIDE 5MG/DAY · SYSTEM · TRANSDERMAL

Approval history

2022-03-11Type 3 - New Dosage Form · Original · standard — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →